Status:
UNKNOWN
Orcellex® Brush Versus Cervex-Brush® on Vault Smear Adequacy in Patients Treated With Radiotherapy for Cervical Cancer
Lead Sponsor:
Princess Margaret Hospital, Hong Kong
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Vaginal vault cytology is commonly used for follow-up surveillance in patients treated for cervical cancer. It is known that the smear inadequacy rate is high, especially in patients post-radiotherapy...
Detailed Description
Patients with cervical cancer treated with primary irradiation will be recruited at their routine post-treatment surveillance follow-up in the out-patient clinic, in the order of their appointment tim...
Eligibility Criteria
Inclusion
- Patients with cervical cancer treated with primary radiotherapy
- Patients aged 18 years or older
- Patients requiring vaginal vault cytology for follow-up surveillance
Exclusion
- Patients who refuse vaginal examination or vaginal vault smear at follow-up.
- Patients who have visible tumour at vaginal vault requiring direct biopsy at speculum examination.
- Patients who cannot understand the study purpose and procedure.
- Patients who cannot read the words written in Chinese or English.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04461574
Start Date
July 1 2020
End Date
June 30 2022
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Hong Kong, Hong Kong, 000